Login / Signup

Estimating the variance for heterogeneity in arm-based network meta-analysis.

Hans-Peter PiephoLaurence V MaddenJames RogerRoger PayneEmlyn R Williams
Published in: Pharmaceutical statistics (2018)
Network meta-analysis can be implemented by using arm-based or contrast-based models. Here we focus on arm-based models and fit them using generalized linear mixed model procedures. Full maximum likelihood (ML) estimation leads to biased trial-by-treatment interaction variance estimates for heterogeneity. Thus, our objective is to investigate alternative approaches to variance estimation that reduce bias compared with full ML. Specifically, we use penalized quasi-likelihood/pseudo-likelihood and hierarchical (h) likelihood approaches. In addition, we consider a novel model modification that yields estimators akin to the residual maximum likelihood estimator for linear mixed models. The proposed methods are compared by simulation, and 2 real datasets are used for illustration. Simulations show that penalized quasi-likelihood/pseudo-likelihood and h-likelihood reduce bias and yield satisfactory coverage rates. Sum-to-zero restriction and baseline contrasts for random trial-by-treatment interaction effects, as well as a residual ML-like adjustment, also reduce bias compared with an unconstrained model when ML is used, but coverage rates are not quite as good. Penalized quasi-likelihood/pseudo-likelihood and h-likelihood are therefore recommended.
Keyphrases
  • systematic review
  • clinical trial
  • healthcare
  • study protocol
  • magnetic resonance imaging
  • magnetic resonance
  • phase ii
  • health insurance
  • contrast enhanced
  • affordable care act